Scoop has an Ethical Paywall
Scoop InfoPages
This InfoPage in unregistered, if this is your news page register Pacific Edge for InfoPages here.
Pacific Edge - Latest News [Page 4]
Cxbladder is Supreme Winner at NZ Innovators Awards
Friday, 18 October 2013, 1:02 pm | Pacific Edge
Pacific Edge is the 2013 Supreme Winner of the NZ Innovators Award for Cxbladder, its novel gene test for the detection and management of bladder cancer.' More >>
First Commercial Sales Achieved for Cxbladder in the USA
Friday, 18 October 2013, 11:52 am | Pacific Edge
Cancer diagnostic specialist Pacific Edge (NZX:PEB) is delighted to announce that it has completed the first commercial sales of Cxbladder tests signalling the start of the commercial revenue for the company in the US. The tests were ordered by US ... More >>
40 million Americans provided access to Cxbladder
Wednesday, 16 October 2013, 3:22 pm | Pacific Edge
Pacific Edge (NZX:PEB), a cancer diagnostic company leading in the development and commercialisation of molecular diagnostic tests, has signed an agreement with FedMed, a national preferred provider network in the United States, to make Cxbladder available ... More >>
US accolade with accreditation granted to Pacific Edge NZ
Wednesday, 2 October 2013, 12:09 pm | Pacific Edge
Cancer diagnostic specialist Pacific Edge has joined an elite group of organisations outside the United States with the registration of Pacific Edge Diagnostics’ Dunedin laboratory to conduct Cxbladder tests under the CLIA regulatory process. More >>
Cxbladder excels in New Zealand
Tuesday, 10 September 2013, 11:26 am | Pacific Edge
New Zealand clinicians and healthcare providers are excited about Pacific Edge Limited’s cancer detection system Cxbladder for its ability to detect bladder cancer with a high degree of accuracy. More >>
Pacific Edge appoints distinguished cancer researcher
Wednesday, 10 July 2013, 3:06 pm | Pacific Edge
Bryan Williams FRSNZ, FAA, who has a distinguished career in cancer research and international business, has accepted appointment to the Board of Pacific Edge Limited as an Independent Director. More >>
MidCentral DHB first in New Zealand to utilise Cxbladder
Thursday, 30 May 2013, 11:39 am | Pacific Edge
MidCentral District Health Board, based in Palmerston North, is set to become the first district health board in New Zealand to become a commercial customer for Pacific Edges diagnostic cancer test Cxbladder. MidCentral will be looking to provide patients ... More >>
China Grants Patent For Detection of Gastric Cancer
Thursday, 16 May 2013, 5:30 pm | Pacific Edge
China, with one of the highest incidences of stomach (Gastric) cancer in the world, has granted Pacific Edge Limited (the Company) its patent, ‘Detection of Gastric Cancer’. This patent defines technology that can be used for the diagnosis of gastric ... More >>
Pacific Edge’s US laboratory receives CLIA registration
Monday, 18 March 2013, 1:40 pm | Pacific Edge
Cancer diagnostic specialist Pacific Edge has achieved a major milestone with notification that its commercial laboratory in Hershey, Pennsylvania, has gained registration under the CLIA1 regulatory process clearing the way for the launch of Cx bladder ... More >>
Pacific Edge Appoints Director to US Board
Tuesday, 12 March 2013, 10:59 am | Pacific Edge
Pacific Edge has taken a further significant step in the commercialisation in the United States of its ground breaking cancer diagnostic test, Cx bladder , with a high calibre appointment to its US subsidiary, Pacific Edge Diagnostics USA, PEDUSA ... More >>
Pacific Edge Diagnostics NZ appoints NZ-Australia Manager
Tuesday, 5 March 2013, 10:36 am | Pacific Edge
Pacific Edge Diagnostics NZ is pleased to announce the appointment of Brent Pownall as Commercial Manager. Brent Joins the team in Dunedin from Auckland and will lead the commercial activity of Pacific Edge’s innovative and non-invasive bladder cancer ... More >>
US Laboratory complete– regulatory approval process underway
Wednesday, 17 October 2012, 1:14 pm | Pacific Edge
US Laboratory complete– regulatory approval process underway Cancer diagnostic company Pacific Edge Limited has completed its US$3.7 million laboratory in the United States on-schedule and within budget and is now preparing for registration under ... More >>
Pacific Edge - CEO presentation at AGM
Monday, 27 August 2012, 3:39 pm | Pacific Edge
Summary of Chief Executive’s presentation to the Annual Shareholders Meeting held in Dunedin on 23 August 2012 More >>
Efficacy of Cxbladder® test
Monday, 6 August 2012, 10:22 am | Pacific Edge
The prestigious American Journal of Urology has published further evidence that confirms the effectiveness of Pacific Edge’s Cx bladder ® test for detecting bladder cancer. More >>
Pacific Edge builds platform and prepares for launch
Friday, 29 June 2012, 6:57 pm | Pacific Edge
Key customers in the United States are already being primed for the launch of Pacific Edge’s novel diagnostic test for bladder cancer, Cx bladder ® on track for March 2013. More >>
Pacific Edge Builds Platform - Cx bladder
Friday, 29 June 2012, 4:26 pm | Pacific Edge
Key customers in the United States are already being primed for the launch of Pacific Edge’s novel diagnostic test for bladder cancer, Cx bladder ® on track for March 2013. More >>
Labtests Exclusive Sales for Novel Diagnostic Cxbladder
Tuesday, 27 March 2012, 11:34 am | Pacific Edge
Labtests Exclusive Sales for Pacific Edge’s Novel Diagnostic Cx bladder ® in Auckland and Northland More >>
Pacific Edge awarded more patents for cancer diagnostics
Monday, 7 November 2011, 1:22 pm | Pacific Edge
Dunedin-based biomedical company Pacific Edge has added to its suite of patents with patents having issued in Europe, Australia, and New Zealand for the company’s technology for the detection of gastric cancer. More >>
Pacific Edge awarded patent in Singapore
Tuesday, 23 August 2011, 12:27 pm | Pacific Edge
Pacific Edge (the “Company”) has recently been awarded a patent in Singapore for its colorectal cancer prognostic technology and anticipates that the patent will issue in other targeted countries over the next 12 to 24 months. More >>
Cxbladder® Kit Receives Regulatory Registration in Australia
Wednesday, 15 June 2011, 1:17 pm | Pacific Edge
Pacific Edge Limited’s flagship product Cxbladder® has received registration under the Australian regulatory body Therapeutic Goods Administration (TGA). The TGA registration is effective immediately and permits Pacific Edge and their Australian ... More >>
